Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Beibei Zhai
Observed names:
B. Zhai,
Bei-Bei Zhai,
BeiBei Zhai,
Zhai, Beibei
Institution:
Vancouver Prostate Centre
Observed institutions:
Vancouver Coastal Health,
University of British Columbia,
Second Military Medical University,
Changhai Hospital,
Eastern Hepatobiliary Surgery Hospital,
Vancouver Coastal Health Research Institute,
Vancouver Prostate Centre,
McGill University
show all 8
ORCID:
0009-0001-6303-6313
Observed ORCID:
0009-0001-6303-6313
OpenAlex ID:
A5010412450
Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines
2011
·
Lu Cao
, Yanming Zhou
, et al.
·
BMC Gastroenterology
·
283
PDF
Hepatoma-derived growth factor-related protein 2 promotes DNA repair by homologous recombination
2015
·
Annika Baude
, Tania Løve Aaes
, et al.
·
Nucleic Acids Research
·
50
PDF
Leukotriene B4 BLT Receptor Signaling Regulates the Level and Stability of Cyclooxygenase-2 (COX-2) mRNA through Restricted Activation of Ras/Raf/ERK/p42 AUF1 Pathway
2010
·
Beibei Zhai
, Huiqing Yang
, et al.
·
Journal of Biological Chemistry
·
33
A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma
2023
·
Louise Ramos
, Sarah Truong
, et al.
·
Clinical Cancer Research
·
28
PDF
Dianhydrogalactitol induces replication-dependent DNA damage in tumor cells preferentially resolved by homologous recombination
2018
·
Beibei Zhai
, Anne Steinø
, et al.
·
Cell Death and Disease
·
19
PDF
Overexpression of transglutaminase 4 and prostate cancer progression: a potential predictor of less favourable outcomes
2013
·
Zhi Cao
, Yang Wang
, et al.
·
Asian Journal of Andrology
·
19
PDF
Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer
2021
·
Htoo Zarni Oo
, Zoltan Lohinai
, et al.
·
Cancers
·
17
PDF
Alternative polyadenylation is a determinant of oncogenic Ras function
2021
·
Aishwarya Subramanian
, Mathew Hall
, et al.
·
Science Advances
·
14
MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK
2015
·
Beibei Zhai
, Xiaofeng Zhang
, et al.
·
Tumor Biology
·
13
Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors
2024
·
Nastaran Khazamipour
, Htoo Zarni Oo
, et al.
·
EMBO Molecular Medicine
·
9
PDF
Prostaglandin E2-Dependent Phosphorylation of RAS Inhibition 1 (RIN1) at Ser 291 and 292 Inhibits Transforming Growth Factor-β-Induced RAS Activation Pathway in Human Synovial Fibroblasts: Role in Cell Migration
2016
·
Casimiro Gerarduzzi
, QingWen He
, et al.
·
Journal of Cellular Physiology
·
9
Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells
2020
·
Beibei Zhai
, Yue Li
, et al.
·
Cell Death and Disease
·
7
PDF
Molecular mechanisms of dianhydrogalactitol (VAL-083) in overcoming GBM chemoresistance
2016
·
A. Steino
, B. Zhai
, et al.
·
European Journal of Cancer
·
2
Abstract 4186: Discovery of novel PARP1-selective inhibitors for treatment of brain tumors using artificial intelligence
2025
·
Sarah Truong
, Beibei Zhai
, et al.
·
Cancer Research
·
1
Data from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma
2023
·
Louise Ramos
, Sarah Truong
, et al.
·
1
Abstract A109: DNA-damaging agent dianhydrogalactitol (VAL-083) targets HR repair pathway and suggests combination therapy with topoisomerase and PARP inhibitors
2018
·
Beibei Zhai
, Guangan He
, et al.
·
Molecular Cancer Therapeutics
·
1
Abstract 2985: Molecular mechanisms of dianhydrogalactitol (VAL-083) in cancer treatment
2016
·
Beibei Zhai
, Anne Steino
, et al.
·
Cancer Research
·
1
433 Molecular and Cellular Mechanisms Regulating Cross-talk Between the Cyclooxygenase and Lipoxygenase Biosynthetic Axes
2008
·
B. Zhai
, Q. He
, et al.
·
Osteoarthritis and Cartilage
·
1
PDF
Abstract 1743: A novel brain-penetrant dual ATR-mTOR inhibitor for PTEN-deficient cancers
2026
·
Sarah Truong
, Beibei Zhai
, et al.
·
Cancer Research
Abstract 6373: Development of a lipid nanoparticle formulation of the bifunctional PARP and HDAC inhibitor kt-3283.
2026
·
Sarah Truong
, Samar Alsudir
, et al.
·
Cancer Research
Supplementary Figure S2 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma
2025
·
Louise Ramos
, Sarah Truong
, et al.
Supplementary Figure S5 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma
2025
·
Louise Ramos
, Sarah Truong
, et al.
Supplementary Figure S1 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma
2025
·
Louise Ramos
, Sarah Truong
, et al.
Supplementary Figure S4 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma
2025
·
Louise Ramos
, Sarah Truong
, et al.
DNAR-05. Discovery and development of a novel CNS-penetrating ATR inhibitor
2025
·
Jeffrey Bacha
, Sarah Truong
, et al.
·
Neuro-Oncology
PDF
Show more works
View as search
Works count:
99
Citation count:
507
H-index:
9
I10-index:
9
Year
Topic
Type
